Company Briacell Therapeutics Corp Toronto S.E.
Equities
CA10778Y1043
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 16-10-31 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 16-01-31 |
Chief Tech/Sci/R&D Officer | 53 | 21-04-30 | |
Chief Tech/Sci/R&D Officer | 62 | 22-02-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 16-05-09 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-08-30 |
Rebecca Taub
BRD | Director/Board Member | 71 | 18-03-06 |
Director/Board Member | 66 | 19-03-17 | |
William Williams
CEO | Chief Executive Officer | 68 | 16-10-31 |
Jane Gross
BRD | Director/Board Member | 67 | 21-10-31 |
Chairman | 39 | 19-02-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,981,726 | 13,137,190 ( 82.20 %) | 0 | 82.20 % |
Company contact information
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |